227 related articles for article (PubMed ID: 30746785)
21. Aptamers and SELEX in Chemistry & Biology.
Famulok M; Mayer G
Chem Biol; 2014 Sep; 21(9):1055-8. PubMed ID: 25237853
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Colorectal Cancer Cell Proliferation by Regulating Platelet-Derived Growth Factor B Signaling with a DNA Aptamer.
Sae-Lim S; Soontornworajit B; Rotkrua P
Asian Pac J Cancer Prev; 2019 Feb; 20(2):487-494. PubMed ID: 30803211
[TBL] [Abstract][Full Text] [Related]
23. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
24. DNA aptamers selection for carcinoembryonic antigen (CEA).
Izabella Abreu de Melo M; Rodrigues Correa C; da Silva Cunha P; Miranda de Góes A; Assis Gomes D; Silva Ribeiro de Andrade A
Bioorg Med Chem Lett; 2020 Aug; 30(15):127278. PubMed ID: 32527457
[TBL] [Abstract][Full Text] [Related]
25. Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform.
Ouellet E; Foley JH; Conway EM; Haynes C
Biotechnol Bioeng; 2015 Aug; 112(8):1506-22. PubMed ID: 25727321
[TBL] [Abstract][Full Text] [Related]
26. Differentiating breast cancer molecular subtypes using a DNA aptamer selected against MCF-7 cells.
Liu M; Yang T; Chen Z; Wang Z; He N
Biomater Sci; 2018 Nov; 6(12):3152-3159. PubMed ID: 30349922
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of DNA aptamers against Escherichia coli using a bacterial cell-systematic evolution of ligands by exponential enrichment approach.
Kim YS; Song MY; Jurng J; Kim BC
Anal Biochem; 2013 May; 436(1):22-8. PubMed ID: 23357235
[TBL] [Abstract][Full Text] [Related]
28. Absolute quantification of cell-bound DNA aptamers during SELEX.
Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
[TBL] [Abstract][Full Text] [Related]
29. A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy.
Zhang L; Wang M; Zhu Z; Ding C; Chen S; Wu H; Yang Y; Che F; Li Q; Li H
Int J Nanomedicine; 2021; 16():3217-3240. PubMed ID: 34007175
[TBL] [Abstract][Full Text] [Related]
30. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
Zhong Y; Zhao J; Li J; Liao X; Chen F
Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
[TBL] [Abstract][Full Text] [Related]
31. Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX.
Wang G; Liu J; Chen K; Xu Y; Liu B; Liao J; Zhu L; Hu X; Li J; Pu Y; Zhong W; Fu T; Liu H; Tan W
Sci Rep; 2017 Aug; 7(1):7179. PubMed ID: 28775305
[TBL] [Abstract][Full Text] [Related]
32. Selection of a DNA aptamer that binds 8-OHdG using GMP-agarose.
Miyachi Y; Shimizu N; Ogino C; Fukuda H; Kondo A
Bioorg Med Chem Lett; 2009 Jul; 19(13):3619-22. PubMed ID: 19450981
[TBL] [Abstract][Full Text] [Related]
33. Glycan-Imprinted Magnetic Nanoparticle-Based SELEX for Efficient Screening of Glycoprotein-Binding Aptamers.
Ma Y; Li X; Li W; Liu Z
ACS Appl Mater Interfaces; 2018 Nov; 10(47):40918-40926. PubMed ID: 30379519
[TBL] [Abstract][Full Text] [Related]
34. Single-walled carbon nanotubes (SWCNTs)-assisted cell-systematic evolution of ligands by exponential enrichment (cell-SELEX) for improving screening efficiency.
Tan Y; Guo Q; Xie Q; Wang K; Yuan B; Zhou Y; Liu J; Huang J; He X; Yang X; He C; Zhao X
Anal Chem; 2014 Oct; 86(19):9466-72. PubMed ID: 25184732
[TBL] [Abstract][Full Text] [Related]
35. Advances in Oligonucleotide Aptamers for NSCLC Targeting.
Rotoli D; Santana-Viera L; Ibba ML; Esposito CL; Catuogno S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842557
[TBL] [Abstract][Full Text] [Related]
36. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
Ouellet E; Lagally ET; Cheung KC; Haynes CA
Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
[TBL] [Abstract][Full Text] [Related]
37. Selection and Identification of Chloramphenicol-Specific DNA Aptamers by Mag-SELEX.
Duan Y; Gao Z; Wang L; Wang H; Zhang H; Li H
Appl Biochem Biotechnol; 2016 Dec; 180(8):1644-1656. PubMed ID: 27613616
[TBL] [Abstract][Full Text] [Related]
38. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
[TBL] [Abstract][Full Text] [Related]
39. Aptamers: new arrows to target dendritic cells.
Ganji A; Varasteh A; Sankian M
J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
[TBL] [Abstract][Full Text] [Related]
40. Selection of a high-affinity and in vivo bioactive ssDNA aptamer against angiotensin II peptide.
Heiat M; Ranjbar R; Latifi AM; Rasaee MJ
Peptides; 2016 Aug; 82():101-108. PubMed ID: 27298205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
